How the new medicare drug benefit could affect vulnerable populations
- PMID: 16403761
- PMCID: PMC1403812
- DOI: 10.1377/hlthaff.25.1.248
How the new medicare drug benefit could affect vulnerable populations
Abstract
This study estimates how out-of-pocket drug costs could change for vulnerable populations (racial and ethnic minorities, the near-poor, and seniors with a greater burden of chronic conditions) who qualify for the standard Medicare drug benefit. Although the new benefit might be associated with modest-to-moderate declines in out-of-pocket spending for seniors who do not qualify for subsidies, the savings might not be shared equitably and therefore might not reduce financial barriers to medication use for these populations.
References
-
- Henry J. Kaiser Family Foundation, The Medicare Prescription Drug Benefit (Menlo Park, Calif.: Kaiser Family Foundation, 2005).
-
- U.S. House Committee on Ways and Means, Estimating the Cost of the Medicare Modernization Act (Washington: Congressional Budget Office, 2004).
-
- M. Moon, How Beneficiaries Fare under the New Medicare Drug Bill (New York: Commonwealth Fund, 2004) - PubMed
- J. Mays et al., Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending in 2006 (Menlo Park, Calif.: Kaiser Family Foundation, 2004)
- Stuart B, et al. “Riding the Rollercoaster: The Ups and Downs in Out-of-Pocket Spending under the Standard Medicare Drug Benefit,”. Health Affairs. 2005;24(4):1022–1031. - PubMed
-
- Moon, How Beneficiaries Fare; and Mays et al., Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending.
-
- U.S. DHHS, National Healthcare Disparities Report (Rockville, Md.: DHHS, 2004).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical